TABLE 3.
Baseline Characteristics of the first 20 randomized patients
| Age (years) | 67.0 (60.9,74.0) |
| Male | 15 (75.0) |
| African‐American | 9 (45.0) |
| Caucasian | 10 (50.0) |
| Body mass index | 28.7 (25.8,41.5) |
| Diabetes mellitus | 9 (45.0) |
| Hypertension | 16 (80.0) |
| Hyperlipidemia | 15 (75.0) |
| Coronary artery disease | 6 (30.0) |
| Stroke | 2 (10.0) |
| Atrial fibrillation or flutter | 3 (15.0) |
| Chronic obstructive pulmonary disease | 3 (15.0) |
| Chronic kidney disease | 6 (30.0) |
| Current or former smoker | 7 (35.0) |
| Time from symptom onset to randomization (days) | 8.5 (6.0,14.0) |
| Dyspnea | 15 (75) |
| Temperature | 37.3 (36.8,37.9) |
| Hospitalized requiring invasive mechanical ventilation | 4 (20.0) |
| Hospitalized requiring nasal high‐flow oxygen or noninvasive ventilation, or both | 6 (30.0) |
| Hospitalized requiring supplemental oxygen | 8 (40.0) |
| Hospitalized, not requiring supplemental oxygen | 2 (10.0) |
| High sensitivity troponin T (ng/L) (reference range < 12 ng/L) | 21.0 (14.5,53.0) |
| N‐terminal pro B‐type natriuretic peptide (pg/mL) (reference range < 125 pg/mL) | 313.0 (208.0,819.0) |
| C reactive protein (mg/dL) (reference range 0.0‐0.4 mg/dL) | 16.2 (10.2, 20.8) |
| Ferritin (ng/mL)(reference range 14.7‐205.1 ng/mL) | 1012.2 (589.4,1962.5) |
| D‐dimer (ng/mL)(reference range < 500 ng/mL) | 1400 (730,1940) |
| Left ventricular ejection fraction (%) | 55 (55,60) |
Note: Expressed as n (%) or median (quartile 1, quartile 3).